Topic Listing for NxStage Medical

Accounting Income Taxes Accounting Stock-based Awards
Acquisition-related Exit Activity Accounted Purchase Accounting Aggregated Option Exercises 2005 Year-end Values Table
Aggregated Option Exercises Last Year-end Values Agreement Davita Confers Certain Geographic Market Rights Limits
Allocation Purchase Price Annual Cash Incentive Bonus
Annual Report Form 10-k Annual Short-term Incentive Awards
Anti-kickback Statutes Anti-takeover Provisions Restated Certificate Incorporation Amended Bylaws Delaware
Appendix Appraisal Rights
Audit Committee Audit Committee Report
Audited Financial Statements Base Salary
Beneficial Ownership Reporting Compliance Billing
Blood Tubing Purchase Agreement Davita Inc Board Committees
Board Determination Independence Board Meetings Attendance
Board Recommendation Broker Non-votes Abstentions
Business Activities Involve Hazardous Materials Require Compliance Environmental Business Results Operations Negatively Impacted General Economic Financial
Buttonhole Needle Set Cannot Accurately Predict Size Home Hemodialysis Market Smaller
Cash Equivalents Marketable Securities Cautionary Notice Regarding Forward-looking Statements
Certain Products Recently Developed Party Manufacturers Limited Manufacturing Certain Products Recently Developed Transitioned Manufacturing New Locations
Certain Products Recently Developed Transitioning Manufacturing New Locations Certification Pursuant Rule 13a-14 15d-14 Adopted 302 Sarbanes-oxley
Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act Changes Reimbursement Acute Kidney Failure Negatively Affect Adoption
Changes Reimbursement Treatment Esrd Affect Adoption System Level Chronic Care
Clinical Experience Results Code Business Conduct Ethics
Common Preferred Stock Communicating Independent Directors
Comparative Stock Performance Graph Comparison Cumulative Total Return Among Nxstage Medical Inc
Compensation Chief Executive Officer 2005 Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Directors Compensation Discussion Analysis
Compensation Paid Directors Executive Officers Compensation Philosophy
Compete Against Other Dialysis Equipment Manufacturers Much Greater Competition
Compliance 162 Code Components Executive Compensation Program
Components Executive Compensation Program 2007 Components Executive Compensation Program 2008
Comprehensive Income Loss Conditions Consummating Closing Private Placement
Confidentiality Agreements Employees Others Not Adequately Prevent Disclosure Continue Commercialize System Difficulty Managing Growth Expanding Operations
Continue Commercialize System Streamline Other Products Difficulty Managing Continuing Fda Regulation
Contract Manufacturers Fail Comply Fdas Quality System Regulations Conversion
Corporate Governance Guidelines Cost Revenues
Cost Revenues Gross Deficit Cost Revenues Gross Profit
Cost Revenues Gross Profit Deficit Costs Increased Significantly Result Operating Public Management Required
Credit Security Agreement Critical Care
Current Medicare Reimbursement Rates Limit Price Market System Currently Obligations Contracts Dialysis Clinics Hospitals Protect Privacy
Currently Obligations Contracts Dialysis Clinics Protect Privacy Patient Customer Support Services
Davita Key Customer System In-center Product Lines Partial Davita National Service Provider Agreement
Delivery Security Holder Documents Depend Services Senior Executives Certain Key Engineering Scientific
Dilutive Effect Director Attendance Annual Meeting Stockholders
Director Compensation Director Nomination Process
Director Nominees Distribution
Distribution Costs Represent Significant Percentage Overall Dependent Fuel Distribution Expenses
Dividends Documents Incorporated Reference
Elements Indirect Pay Employee Stock Purchase Plan
Employees Entrada
Equity Award Grant Practices Equity Compensation Plan Information
Equity Financing Equity Security Price Risk
Estimates Even Obtain Necessary Fda Clearances Approvals Suppliers Fail
Evolve Primarily Involved Development Dialysis Products Also Commercialization Exact Name Registrant Specified Charter
Executive Base Salary 2005 Executive Compensation
Executive Compensation Determined Executive Compensation Philosophy Objectives
Executive Officers Executive Officers Directors Current Principal Stockholders Own Large
Expect Derive Significant Percentage Future Revenues Rental Sale Expect Derive Substantially Future Revenues Rental Sale System
Face Risks Associated Having International Manufacturing Operations Unable Failure Obtain Regulatory Approval Foreign Jurisdictions Prevent Marketing
Fair Value Financial Instruments Concentration Credit Risk False Claims Laws
Fda Clearance Procedures Fda Regulatory Clearance Status
Federal Income Tax Consequences Fees Independent Registered Public Accounting Firm
Field Equipment Find Additional Information
Find Information Fistula Apheresis Needles Masterguard Anti-stick Needle Protectors
Food Drug Administration Foreign Currency Exposure
Foreign Currency Translation Transactions Foreign Governments Tend Impose Strict Price Controls Adversely
Foreign Regulation Medical Devices Foreign User
Form 10-k Form Warrant
Fraud Abuse Laws General
General Administrative Goodwill
Grants Plan-based Awards Year-end 2007 Grants Plan-based Awards Year-end 2008
Grow Through Additional Acquisitions Dilute Existing Shareholders Involve Had Limited Sales Marketing Customer Service Distribution Experience
Held 2006 Held 2007
Held 2008 Held 2009
Holders Home
Home In-center Care Home In-center Care Markets
Home Market Householding Proxy Materials
Important Information Annual Meeting Voting In-center
In-center Critical Care Market In-center Segment
In-center Segment Relies Heavily Third-party Distributors Inability Successfully Integrate Operations Personnel Medisystems Nxstage Significant
Income Taxes Index Consolidated Financial Statements
Information Proxy Statement Information Relating Equity Awards Holdings
Intangibles Other Long-lived Assets Interest Income Expense
Interest Rate Exposure Inventory
Inventory Valuation Issuer Purchases Equity Securities
Kidney Transplantation Becomes Viable Treatment Option Patients Esrd Kidney Transplantation Becomes Viable Treatment Option Patients Market
Largest Dialysis Clinic Chains United States Affiliated Contractual Legislative Regulatory Reform Healthcare System Affect Ability Sell
Limited Operating Experience History Net Losses Accumulated Deficit Liquidation Rights
Long-term Incentive Awards Long-term Incentive Grants 2005
Long-term Incentives Maintain Insurance Levels Deemed Adequate Management However Future
Managements Report Internal Control Over Financial Reporting Manufacturing
Market Information Medic
Medisystems Acquisition Medisystems Business Relies Heavily Third-party Distributors
Medisystems Corporation Medisystems Supply Agreement
Membrana Merrill Lynch Credit Facility
Modifications Marketed Devices Require New Regulatory Clearances Pre-market National Service Provider Agreement Davita Confers Certain Geographic
Needle Purchase Agreement Davita Inc Net Loss Per Share
Nominating Corporate Governance Committee Not Anticipate Paying Cash Dividends Accordingly Stockholders Rely
Not Long-term Supply Contracts Third-party Suppliers Nxstage Medical Inc
Off-balance Sheet Arrangements Only Recently Began Marketing System Hemodialysis Dialysis Clinics
Operating Expenses Option Exercises Stock Vested
Other Compensation Plans Other Income Expense
Other Matters Overview
Part Performance-based Annual Bonus 2005
Policies Procedures Regarding Review Approval Ratification Related Person Pre-approval Policies Procedures
Principles Consolidation Basis Presentation Privacy Security
Proceeds Product Reliability Issue
Products Infringe Intellectual Property Rights Others Lead Litigation Products Services
Property Equipment Field Proposal Amendment 2005 Employee Stock Purchase Plan
Proposal Approval Amendment 2005 Stock Incentive Plan Proposal Election Directors
Proposal Ratification Selection Independent Registered Public Accounting Firm Provision Foreign Income Taxes
Provision Income Taxes Proxy Voted
Purchase Accounting Treatment Acquisitions Decrease Net Income Foreseeable Purchase Price
Purpose 2005 Plan Purpose Special Meeting
Quorum Readyset
Reasons Private Placement Including Closing Reasons Proposal
Recent Accounting Pronouncements Recent Developments
Recommendation Board Directors Record Date Shares Outstanding
Redemption Rights Registration Rights
Reimbursement Related-party Transactions
Relationship David Utterberg Relationship Jonathan Silverstein
Relationship Medisystems Corporation Relationship Sprout Entities
Rely Heavily Davita Key Customer System Medisystems Product Report Audit Committee
Report Compensation Committee Report Independent Registered Public Accounting Firm
Require Significant Capital Build Business Financing Not Available Research Development
Results Operations Revenue Recognition
Revenues Review Other Financial Disclosures
Revocability Proxies Revocation Proxies
Risks Related Intellectual Property Risks Related Operations
Rule 14a-101 Sales Marketing
Securities Authorized Issuance Equity Compensation Plan Securities Authorized Issuance Equity Compensation Plans
Segment Reporting Selling Marketing
Severance Change-of-control Benefits Short-term Incentive Awards
Signatures Signatures Appear Following Page
Significant Amount Field Equipment Ability Effectively Manage Asset Significant Amount System Field Equipment Ability Effectively Manage
Signing Bonuses Solicitation Proxies
Special Recognition Awards Stock Option Restricted Awards
Stock Price Likely Volatile Market Common Drop Stock-based Compensation
Stockholder Approval Nasdaq Marketplace Rules Stockholder Proposals 2007 Annual Meeting
Stockholder Proposals 2008 Annual Meeting Stockholder Proposals 2009 Annual Meeting
Stockholder Proposals 2010 Annual Meeting Streamline
Subject Costly Damaging Product Liability Claims Not Able Subject Damages Resulting Claims Employees Wrongfully Used Disclosed
Subject Risk Costly Damaging Product Liability Claims Not Subject Significant Regulation Primarily Fda Cannot Market Commercially
Substantial Sales Common Stock Market Existing Stockholders Price Success Business Depends Services Each Senior Executives Well
Success Depend Ability Achieve Market Acceptance System Success Growth Business Depend Ability Achieve Expanded Market
Summary 2005 Employee Stock Purchase Plan Summary Compensation Information
System System Segment
Table Contents Tabulation
Tax Considerations Terms Private Placement
Terms Securities Purchase Agreements Applicable Closing Terms Voting Agreements
Terms Warrants Transducer Protectors Viraguard
Unable Convince Additional Hospitals Healthcare Providers Benefits Products Unable Convince Hospitals Healthcare Providers Benefits Products Treatment
Unable Improve Product Reliability Performance Typically Experienced Early Unable Improve Product Reliability System Ability Grow Business
Unable Protect Intellectual Property Prevent Parties Lose Significant User
User Except American User Except Japan
User Only Valuation Business Combinations
Vote Required Voting Instructions
Voting Proxies Special Meeting Voting Proxy
Voting Rights Voting Shares Held Street Name
Warrants Warranty Costs
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki